• Latest Posts

64 Million RSV Infections Per Year: Perhaps Alpaca Nanobodies Will Save Infant Lives

Global NGS Leader’s Influence in European Bioinformatics Field is Spreading Interest in Microbiomics

A New Vaccine Against Pneumonia and Meningitis Reaches Human Trials..

Biotech of the week: Opsona Therapeutics, The Leading Irish Immuno-Oncology Biotech

What are Money-Magnet Moderna’s future plans? French Founding CEO explains here

Curetis Molecular Diagnostics IPO Exceeds Expectations


Sanofi’s COBRA Research to Tackle the Challenge of A Universal Influenza Vaccine for Winter

Interview: CureVac, the ‘RNA’ People’s Pioneering Strategy to get mRNA Therapies onto the Market

A Group of French Medics are Questioning the Fastest-Growing Big Biotech in the World…

€100 Million Investment Round Prepares CureVac For Vaccine Expansion

Fighting Infection with a Pioneering Arsenal of Med-Tech Inventions from the UK

Belgian Biotech Seed Investment to Produce Affordable Vaccines for Developing Countries